Mardi Dier - Mar 10, 2025 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
SVP and CFO
Signature
/s/ Mardi Dier
Stock symbol
MDGL
Transactions as of
Mar 10, 2025
Transactions value $
-$83,344
Form type
4
Date filed
3/12/2025, 04:32 PM
Previous filing
Mar 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Sale -$83.3K -258 -2.41% $323.04 10.4K Mar 10, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024.